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Abstract
The capacity of the high-affinity choline transporter (CHT) to
import choline into presynaptic terminals is essential for
acetylcholine synthesis. Ceramic-based microelectrodes,
coated at recording sites with choline oxidase to detect
extracellular choline concentration changes, were attached to
multibarrel glass micropipettes and implanted into the rat
frontoparietal cortex. Pressure ejections of hemicholinium-3
(HC-3), a selective CHT blocker, dose-dependently reduced
the uptake rate of exogenous choline as well as that of choline
generated in response to terminal depolarization. Following
the removal of CHTs, choline signal recordings confirmed that
the demonstration of potassium-induced choline signals and
HC-3-induced decreases in choline clearance require the
presence of cholinergic terminals. The results obtained from
lesioned animals also confirmed the selectivity of the effects of
HC-3 on choline clearance in intact animals. Residual cortical
choline clearance correlated significantly with CHT-immuno-
reactivity in lesioned and intact animals. Finally, synaptosomal
choline uptake assays were conducted under conditions
reflecting in vivo basal extracellular choline concentrations.
Results from these assays confirmed the capacity of CHTs
measured in vivo and indicated that diffusion of substrate
away from the electrode did not confound the in vivo findings.
Collectively, these results indicate that increases in extracel-
lular choline concentrations, irrespective of source, are rapidly
cleared by CHTs.
Keywords: acetylcholine, choline, choline-sensitive micro-
electrodes, choline transporter, choline uptake, hemicholin-
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The cortical mantle receives a dense cholinergic projection
originating from the nucleus basalis of Meynert (nBM) and
the substantia innominata (SI) in the basal forebrain (BF).
The cortical cholinergic input system represents a major
component of the attention systems of the brain; abnormali-
ties in cholinergic neurotransmission have been hypothesized
to contribute to the symptoms of major cognitive disorders
(Everitt and Robbins 1997; Zaborszky 2002; Hasselmo and
McGaughy 2004; Mesulam 2004; Sarter et al. 2005a,b).
The transport of choline into presynaptic terminals, via a
Na+/Cl–-dependent, hemicholinium-3 (HC-3)-sensitive
choline transporter (CHT), is the rate-limiting step of
acetylcholine (ACh) synthesis (Yamamura and Snyder
1972; Guyenet et al. 1973; Atweh et al. 1975; Simon and
Kuhar 1975, 1976; Simon et al. 1976; Blusztajn and
Wurtman 1983; Chatterjee et al. 1987; Saltarelli et al.
1987; Lockman and Allen 2002). HC-3-induced blockade
of the CHT is sufficient to attenuate ACh synthesis and
release (Freeman et al. 1979; Saltarelli et al. 1987).
Rapid and robust changes in the capacity of the CHT to
transport choline have been demonstrated as a result of either
molecular or behavioral/cognitive manipulations (Brandon
et al. 2004; Ferguson et al. 2004; Apparsundaram et al.
2005). Such changes in CHT capacity appear to be caused in
part by altered trafficking of CHTs between intracellular
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domains and the plasma membrane (Ferguson et al. 2003;
Ferguson and Blakely 2004; Apparsundaram et al. 2005).
Several intracellular signaling molecules have been shown to
be involved in the regulation of both CHT surface expression
and CHT capacity (Saltarelli et al. 1990; Gates et al. 2004),
suggesting that the capacity of the CHT is regulated by
multiple cholinergic and possibly non-cholinergic mecha-
nisms. Abnormally regulated CHTs have been hypothesized
to contribute to cognitive impairments (Wurtman 1992;
Slotkin et al. 1994; Sarter and Parikh 2005).
Previous studies determined the properties of CHTs
primarily on the basis of in vitro choline uptake assays.
Data from such assays substantiated the high affinity of
CHTs for choline (Km ¼ 1–10 lM; Haga 1971; Farber et al.
1996; Lockman and Allen 2002) and suggested a consider-
able range of CHT-saturating choline concentrations
(5–30 lM). Furthermore, a close relationship between cho-
linergic neuronal activity and CHT capacity was demons-
trated (Atweh et al. 1975; Simon and Kuhar 1975; Simon
et al. 1976).
Using choline-sensitive microelectrodes and an ampero-
metric method for the measurement of extracellular choline
concentrations in vivo (Burmeister and Gerhardt 2001;
Burmeister et al. 2003; Parikh et al. 2004), the present
experiments were designed to determine the contribution of
the CHT to the clearance of exogenous choline as well as
choline derived from newly released ACh in the rat cortex.
The experimental approaches employed to address these
issues here correspond with those used by Gerhardt and
colleagues for the study of dopamine clearance via dopamine
transporters (Cass et al. 1993). Choline clearance was
determined in either the presence or the absence of a highly
potent and selective inhibitor of CHTs, HC-3 (Guyenet et al.
1973; Simon and Kuhar 1975), in intact animals and
following the removal of cholinergic terminals in the
recording region. In vitro synaptosomal assays were con-
ducted under conditions that mimicked extracellular choline
concentrations determined in vivo, in order to verify the
contribution of CHTs to choline clearance determined
in vivo. The results provide quantitative insights into the
contribution of CHTs in vivo to the clearance of choline
hydrolyzed from local increases in ACh release as well as
that of exogenous choline.
Materials and methods
Subjects
Adult male Fisher/Brown Norway hybrid rats (FBNF1; Harlan,
Indianapolis, IN, USA), weighing 200–250 g at the beginning of the
experiments were used. Animals were individually housed in a
temperature- (23C) and humidity-controlled (45%) environment
and on a 12 h light/dark cycle (lights on at 06:30 h). Animals were
extensively handled prior to the beginning of experiments to
minimize potential confounds resulting from the effects of either
novelty or stress. Food and water were made available ad libitum
(Rodent Chow; Harlan Teklad, Madison, WI, USA). All procedures
were conducted in adherence with protocols approved by the
University Committee on Use and Care of Animals (UCUCA).
Drugs and chemicals
Choline oxidase (CO; EC 1.1.3.17), bovine serum albumin
(BSA), glutaraldehyde, ascorbic acid (AA), dopamine (DA),
choline, hemicholinium-3 (HC-3), acetylthiocholine iodide and
3¢,3¢-diaminobenzidine dihydrochloride (DAB) were all obtained
from Sigma Chemical Co. (St Louis, MO, USA). NafionTM (5%
in a mixture of aliphatic alcohols and water) was obtained from
Aldrich Chemical Co. (Milwaukee, WI, USA). 192-IgG Saporin
(192-SAP) and mouse-IgG saporin (Ms-SAP) were obtained from
Advanced Targeting Systems (San Diego, CA, USA). Rabbit anti-
choline transporter (CHT) polyclonal antibody and goat serum
was from Chemicon (Chemicon International, Temecula, CA,
USA). Alexa Fluor 488-conjugated goat anti-rabbit IgG (highly
cross-adsorbed) and Prolong-Gold anti-fade reagent were obtained
from Molecular Probes (Eugene, OR, USA). [Methyl-3H]Choline
chloride was purchased from Amersham Biosciences Inc.
(Piscataway, NJ, USA). HPLC grade water (Fisher Scientific,
Davis, CA, USA) was used to prepare all solutions. Solutions
used for intracranial injections were prepared in 0.9% NaCl
(pH 7.4) and filtered through 0.22-lm sterile non-pyrogenic filters
(Costar, Corning, NY, USA) prior to use.
Lesion surgery
All surgeries were performed under aseptic conditions. Anesthesia
was induced with 4–5% isoflurane using an anesthesia machine
(Anesco/Surgivet, Waukesha, WI, USA). Rats were placed in a
stereotaxic instrument (model No. 962; David Kopf, Tujunga, CA,
USA) and anesthesia was maintained with 2% isoflurane along with
oxygen at a flow rate of 1 mL/min. Loss of cortical cholinergic
inputs was produced by infusions of 192-SAP into the region of the
cholinergic cell bodies in the nucleus basalis of Meynert and
substantia innominata of the BF. The selective cholinotoxic effects
of 192-SAP, a conjugate of an antibody to the p75 neurotrophin
receptor and the ribosome-deactivating protein saporin, has been
extensively documented (e.g. Book et al. 1992; Holley et al. 1994;
Waite et al. 1994). Animals (n ¼ 10) received bilateral infusions of
192-SAP (0.085 lg/0.5 lL/hemisphere) into BF using the following
coordinates [anterior-posterior, )1.3 mm; medial-lateral, ±2.5 mm
(relative to bregma); dorsal-ventral, )7.2 mm (relative to dura);
Paxinos and Watson 1988]. Sham lesions were produced by infusing
Ms-SAP (0.1 lg/0.5 lL/hemisphere), a conjugate of pre-immune
mouse IgG antibody and saporin, into BF. Infusions were made at a
rate of 0.25 lL/min using a 1-lL Hamilton microsyringe; the needle
remained in place for an additional 4 min following the infusion.
Amperometric recording sessions (see below) were performed three
weeks after lesion surgeries.
Preparation and calibration of choline-sensitive microelectrodes
Choline-sensitive microelectrodes were prepared using ceramic-
based, multisite microelectrodes featuring four 15 · 333 lm
platinum recording sites arranged in side-by-side pairs (see Fig. 1a;
Burmeister et al. 2003; Parikh et al. 2004). Briefly, the selectivity of
the microelectrode for choline was enhanced by applying Nafion
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coatings prior to enzyme application. Nafion is a charged polymer
that limits the access of potentially interfering analytes to the
recording surface; in contrast, the electrode remains permeable for
H2O2, the reporter molecule indicating choline oxidation. CO was
cross-linked with the BSA-glutaraldehyde mixture and immobilized
on the two lower recording sites. The upper two recording sites were
coated only with the BSA-glutaraldehyde solution and served to
record background activity. Enzyme-coated microelectrodes were air
dried at least 48–72 h prior to use. Choline-sensitive microelec-
trodes were calibrated using a FAST-16 electrochemical recording
system (LLC; Quanteon, Nicholasville, KY, USA) prior to implan-
tation in animals. Microelectrodes were dipped in 0.05 M phosphate-
buffered saline (PBS) for 30 min prior to calibration. Calibrations
were performed using fixed potential amperometry by applying a
constant voltage of 0.7 V versus an Ag/AgCl reference electrode
(Bioanalytical Systems Inc., West Lafayette, IN, USA) in a beaker
containing a stirred solution of 0.05 M PBS maintained at 37C.
Amperometric currents were digitized at a frequency of 5 Hz. After
achieving a stable baseline current, aliquots of stock solutions of AA
(20 mM), choline (20 mM) and DA (2 mM) were added to the
calibration beaker such that the final concentrations were 250 lM
AA, 20, 40, 60 and 80 lM choline and 2 lM DA. Normalized
currents recorded from non-CO-coated sites were subtracted from
normalized currents recorded via CO-coated sites (‘self-referen-
cing’) to yield currents that selectively reflected choline concentra-
tions (Burmeister and Gerhardt 2001; Parikh et al. 2004). The slope
(sensitivity), limit of detection (LOD) and linearity (R2) for choline,
as well as selectivity ratio for AA and DA, were calculated in
individual channels as well as in self-referencing mode. To be used
in subsequent in vivo experiments, electrodes were required to meet
the following characteristics: sensitivity for detecting choline,
>3 pA/lM, with a background current of <100 pA; LOD < 300 nM
choline; selectivity for choline : AA, >80 : 1; detection of increa-
sing choline concentrations (20–80 lM), R2 > 0.98.
Fig. 1 Arrangements and dimensions of the four recording areas on
the ceramic-based microelectrodes. Individual recording sites were
333 · 15 lm (see scale for recording site length on the right). The
lower pair of recording sites was typically coated with choline oxi-
dase while the upper pair was used for self-referencing. (b) place-
ment of the recording sites in the frontoparietal cortex and striatum
(the 1 mm scale applies to the schematics b–d). (c) and (d) depict
the location and dimensions of the sampling areas for quantification
of AChE-positive fiber density and CHT-IR in the frontoparietal
cortex and striatum. (e) illustration of the main parameters used to
quantify choline signals, specifically, choline clearance in vivo. Pilot
data indicated that a later phase of the clearance function, bordered
by a 40% and 80% decrease in choline concentration relative to
peak amplitude, is more sensitive to the effects of HC-3 than an
earlier phase which is bordered by a 20% to 60% decrease in
choline concentration. Based on this observation, and using a
modified terminology to describe and quantify transporter-mediated
clearance (see Methods for references), and in addition to signal
amplitude, the uptake rates of an early (TC1) and a later (TC2)
component of the choline clearance function were determined in
(lM/s). Furthermore, the times (s) required for the signal to decline
between 20% and 60% (T20–60) and 40% and 80% (T40–80), relative
to the maximal amplitude, were calculated (in ms).
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In vivo recordings
Recordings were carried out in frontoparietal cortex of rats
anesthetized with urethane (1.25–1.5 g/kg, i.p.; see Fig. 1b for an
illustration of the electrode placement). Animals were placed in a
stereotaxic frame and their body temperatures were maintained at
37C using a Deltaphase isothermal pad (Braintree Scientific,
Braintree, MA, USA). Triple-barrel glass capillaries (1.2 mm ·
0.60 mm, 6 in; A-M systems, Inc., Carlsborg, WA, USA) were
pulled using a micropipette puller (model No. 51210; Stoelting,
Wood Dale, IL, USA) and then bumped against a glass slide until
the inner tip diameter of an individual barrel was 15–20 lm. The
micropipette was attached to the microelectrode using sticky wax
such that the tip of the micropipette was placed between the lower
and upper pairs of recordings sites, and the distance between the tip
and the microelectrode was 70–100 lm. An Ag/AgCl reference
electrode prepared from 200 lm diameter silver wire (A-M Systems)
and was implanted at a site remote to the recording area. The
individual barrels of the micropipette were filled with drug solution
(see below) prior to microelectrode implantation. The microelec-
trode/micropipette assembly was slowly lowered into the frontopa-
rietal cortex (AP, +1.0 mm; ML, ±2.7 mm; DV, )1.0 mm; measured
from bregma), using a microdrive (MO-10; Narishige International,
East Meadow, NY, USA). Drug solutions were ejected from the
micropipettes using PTFE tubing connected to a pressure ejection
system (Picospritzer III; Parker Hannifin Co., Fairfield, NJ, USA) at
2–10 psi for 1–2 s. The ejected volumes were monitored using a
stereomicroscope (Meiji Techno America, San Jose, CA, USA)
fitted with a reticule. Amperometric recordings were made every
100 ms by applying a fixed potential of 0.7 V to the microelectrode
using the FAST-16 recording system (Quanteon). Data were digitized
using FAST-16 software. Experiments began following the stabiliza-
tion of the baseline current for 30–45 min. To determine, in vivo, the
contribution of the CHT to the rapid clearance of exogenous
choline, the effects of HC-3, a potent and selective CHT blocker
(Guyenet et al. 1973; Manaker et al. 1986), were evaluated. In
sham-lesioned controls (n ¼ 8) and 192-SAP-lesioned rats (n ¼
10), the effects of local ejections of 5 mM choline (100–300 nL)
were assessed in the presence and absence of HC-3 (1 and 10 lM).
In each animal, the effects of 3–5 ejections per condition were
tested. In addition, the effects of pressure ejections of 200 nL KCl
(70 mM; Parikh et al. 2004) in sham- and 192-SAP-lesioned rats
served to demonstrate the effects of loss of cholinergic terminals on
depolarization-evoked choline signals. Tests of the effects of KCl
and exogenous choline were separated by 10–15 min to ensure
stable baseline activity. The volumes of either choline or cho-
line + HC-3 pressure ejections were varied by adjusting the pressure
in order to obtain choline signals with uniform amplitudes (20–
25 lM). Uniform amplitudes are a prerequisite for valid comparisons
between the effects of different manipulations on choline uptake
rate, and they limit the variations based on clearance via the
substrate-regulated low-affinity choline transporter (Parikh et al.
2004). The effects of potassium ejections (70 mM), in combination
with HC-3 (1 and 10 lM), served to determine HC-3-sensitive
clearance of choline that is derived from terminal depolarization and
hydrolysis of newly released ACh; these experiments were carried
out in a separate set of animals (n ¼ 5). Previous experiments
demonstrated that KCl-induced choline signals are attenuated by the
administration of either an acetylcholine esterase (AChE) inhibitor
or tetrodotoxin (Parikh et al. 2004). Although we planned to adjust
the volume of pressure ejections of KCl individually (150–200 nL)
in order to obtain uniform signal amplitudes (10–15 lM)
across animals, this was not necessary (see Discussion). To
control for the specificity of the effects of the lesions (below),
KCl-induced signals were also recorded in the dorsal striatum (see
Fig. 1b).
Choline signal analysis
For self-referencing, normalized signals recorded via the non-CO-
coated channel were subtracted from normalized signals obtained at
the CO-coated channel (Burmeister and Gerhardt 2001). Self-
referencing was applied for the analyses of choline signals
associated with relatively high background noise (>3 lM), and if
pressure ejection artifacts were observed on the CO-coated channel.
Five parameters were derived from choline signals and subjected
to statistical analysis: the ratio between the signal amplitude and the
ejection volume (nM of equivalent choline per nL of solution), time
(s) required for the signal to decline between 20 and 60% of the
maximal amplitude (T20)60) and between 40 and 80% of the
maximal amplitude (T40)80), and the choline uptake rate (lM/s) for
the earlier (TC1) and later (TC2) part of the choline clearance function
(see Fig. 1e). TC1 and TC2 were obtained by determining the slope of
the linear regression of data points from the respective part of the
clearance curve. These parameters were selected on the basis of
findings from studies on the clearance of dopamine and serotonin,
including the effects of uptake inhibitors on the clearance of these
transmitters (Wightman et al. 1988; Friedemann and Gerhardt 1992;
Cass et al. 1993; Daws et al. 1997; Zahniser et al. 1999). Generally,
TC1 and T20)60 have been suggested to represent the slope of the
initial linear portion of signal clearance (T20)60), and to reflect the
capacity of DA transporters (Wightman et al. 1988; Zahniser et al.
1999). However, pilot data indicated that the effects of HC-3 on
choline clearance manifest more robustly with respect to an
overlapping but later component of the clearance curve (TC2,
T40)80). Thus, both components of the clearance curve were
analyzed (see Fig. 1e for a graphical illustration of these para-
meters). The average of three responses per manipulation per animal
were used for statistical analyses of clearance data.
Determination of basal extracellular choline concentration
Basal extracellular choline levels were determined in frontoparietal
cortex from CO-coated recording sites by subtracting the in vivo
background current exhibited by these channels from non-CO-
coated channels and dividing the difference by the sensitivity
(calibration slope) of the enzyme-coated channel. The valid
determination of basal extracellular choline levels in vivo required
the use of microelectrodes with the following electrochemical
characteristics: (i) identical background currents on both enzyme-
coated and non-enzyme-coated channels (difference <10 pA) prior
to any analyte addition during calibration; (ii) CO-coated and non-
CO-coated cannels were relatively insensitive to AA as indicated by
a <5 pA change in current in response to the addition of 500 lL of
20 mM AA.
Histochemical and immunohistochemical procedures
After the completion of recordings, animals were transcardially
perfused with 100 mL of ice-cold heparinized saline followed by
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300 mL of 4% paraformaldehyde in 0.1 M PBS (pH 7.4). The brains
were removed and postfixed overnight at 4C and stored in 30%
sucrose in 0.1 M PBS for 72 h. Coronal sections (30 lm) were cut
using a freezing microtome (Leica CM 2000R; Leica Microsystems
Inc., Chantilly, VA, USA) and stored in cryoprotectant solution
(15% glucose, 30% ethylene glycol and 0.04% sodium azide in
0.05 M PBS, pH 7.4) at )20C until further processing. Serial
sections from frontoparietal cortex and the striatum (between 0.5
and 1.00 mm anterior to bregma) were either Nissl-stained or
processed for the histochemical visualization of AChE-positive
fibers in the cortex or CHT-immunoreactivity (IR). Sections
depicting the BF (1.30–1.50 mm posterior to bregma) were
processed only for CHT-IR. Nissl-stained sections were produced
for verification of microelectrode placements. Loss of cholinergic
projections to the cortex was verified and semiquantified (below) on
the basis of sections revealing the density of AChE-positive fibers in
the cortex. Brain sections for AChE staining were processed using
Tago’s method (Tago et al. 1986). AChE-positive fiber density in
the frontoparietal cortex was quantified using a grid counting
technique as described earlier (McGaughy et al. 1996; Burk et al.
2002) using a Leica DM 4000B digital microscope (Nuhsbaum,
McHenry, IL, USA). AChE-positive fibers were counted in
layers III/IV (0.16 mm2) at 400· magnification (see Fig. 1c for an
illustration of the sampling area) and expressed as an average count
from three sections. Note that this method was not intended to
generate absolute and bias-free counts but an estimate of the 192-
SAP-induced decrease in the density of the cholinergic innervation
of the frontoparietal recording region.
CHT-IR
Free-floating sections stored in cryoprotectant solution were thawed
and processed for CHT-IR. Sections were rinsed twice in 0.1 M Tris-
buffered saline (TBS) for 5 min, incubated with blocking buffer
(10% goat serum in 0.1 M TBS) with constant shaking for 60 min
followed by overnight incubation with rabbit anti-CHT antibody
diluted 1 : 350 in dilution buffer (0.1 M TBS containing 1% goat
serum and 0.1% triton X-100) at 4C. The following day, sections
were washed in wash buffer (0.1 M TBS containing 0.1% triton
X-100) four times for 5 min and incubated with 1 : 250 diluted
Alexa Fluor 488 conjugated goat anti-rabbit IgG (Molecular
Probes) for 2 h at 25C. After four 5-min rinses with wash buffer,
the sections were mounted on gelatin-coated slides and coverslipped
with Prolong-Gold antifade reagent. Omission of either primary or
secondary antibody from this procedure eliminated CHT-IR.
Sections were analyzed using a Leica DM4000B fluorescent
microscope equipped with a SPOT Digital Camera and using SPOT
software (Diagnostics Inc., Sterling Heights, MI, USA) and
processed for quantitative image analysis using NIH IMAGE analysis
software ‘IMAGEJ’ (http://rsb.info.nih.gov/ij). The density of CHT-IR
in frontoparietal cortex was expressed as the percentage of
IR-positive pixels in the analyzed area (counting area, 0.16 mm2;
see Fig. 1d). Digitized images were processed in binary mode and
threshold levels were adjusted to enhance the visibility of either
CHT-immunoreactive fibers or cell bodies uniformly among all
sections with the help of a macro created in the software (see
Fig. 1d). Furthermore, the number of CHT-immunopositive neurons
was counted in the BF (1.0 mm2) and, for control purposes, striatum
(1.96 mm2; see Fig. 1d). In all cases, average counts were based on
counts from three sections per region and per animal. Again,
quantification of CHT-IR was not intended to generate absolute
numbers but estimates of the lesion-induced decrease in the density
of CHTs in the cortex and CHT-immunopositive cells in the BF.
Synaptosomal uptake assays
Synaptosomal assays were conducted in order to determine HC-3-
sensitive choline uptake under conditions that approach the total
extracellular choline concentration following choline pressure
ejections in vivo, taking into account basal extracellular choline
concentration determined also in vivo. Choline transport assays were
carried out in synaptosomes prepared from rat frontoparietal cortex
with minor modifications from the method described earlier (Gates
et al. 2004). Briefly, animals (n ¼ 6) were decapitated under
urethane anesthesia (1.5 g/kg; i.p). The brains were quickly
removed and the frontoparietal cortex was dissected out from both
hemispheres on ice-cold surface. The tissues from the two
hemispheres were pooled and homogenized in 0.32 M sucrose.
The homogenate was centrifuged at 1000 g for 4 min at 4C. A
crude synaptosomal fraction was obtained by spinning the resulting
supernatant at 12 500 g for 15 min. The synaptosomal pellet was
re-suspended in Kreb’s bicarbonate buffer (KBB) containing
118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 25 mM NaHCO3,
1.7 mM CaCl2, 10 mM glucose supplemented with 100 lM AA,
10 lM physostigmine and bubbled with 95 : 5 mixture of O2 : CO2.
Protein content was determined by Lowry’s method using a
commercially available kit (Sigma). The synaptosomal suspension
was divided into two fractions and choline uptake assays were
carried out in the absence and presence of a choline concentration
(5 lM), which reflected the results of the in vivo determination of
basal choline concentration (see Results). Aliquots (50 lL) of the
synaptosomal suspension from fraction 1 were mixed with either
50 lL of KBB or KBB containing 10 lM of HC-3. Choline
transport was initiated by incubating 6 lM of [3H]choline at 37C
for 5 min in a shaking water bath. The uptake was terminated by
transferring the tubes to ice bath followed by rapid filtration using a
tissue harvester (Brandel Inc., Gaithersburg, MD, USA). In order to
assess choline uptake under conditions that mirrored the extracel-
lular concentrations of choline determined in vivo, and following the
addition of exogenous choline in the in vivo experiments, aliquots
from fraction 2 were pre-incubated with KBB containing 5 lM
choline at 37C for 3 min. Subsequent methods were identical to
the procedures described for fraction 1 above. At all steps, the final
choline concentration in the synaptosomal suspensions was main-
tained at 5 lM. All uptake assays were carried out in triplicate with
[3H]choline containing 10% labeled choline. Radioactivity counts
were converted into [3H]choline concentration derived from
standard plots and values were normalized to synaptosomal protein
concentration.
Statistical analyses
Statistical analyses were performed using SPSS/PC+ V. 13.0 (SPSS,
Chicago, IL, USA). Repeated measure ANOVAs, with Huynh–Feldt
correction for degrees of freedom where necessary, were employed
to analyze the effects of HC-3 (signal amplitudes/injection volume;
T20)60; T40)80; TC1; TC2). Post-hoc multiple comparisons were
conducted using the least significant difference (LSD) test (alpha ¼
0.05 for all statistical analyses). As only the higher concentration of
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HC-3 was tested in lesioned animals, group-based comparisons of
clearance data, as well as histological and immunohistochemical
data, were carried out using planned, two-tailed, unpaired Student’s
t-tests. Correlations between clearance data and CHT-IR were
carried out by determining Pearson’s r and testing correlation
coefficients for statistical significance. Exact p-values are reported as
per recommendations by Greenwald and colleagues (Greenwald
et al. 1996).
Results
Microelectrode calibration and basal cortical
extracellular choline concentration
Microelectrodes properties (calibration data)
The microelectrodes (n ¼ 20) used for these experiments
displayed a background current of 66.44 ± 4.87 pA and a
sensitivity of 6.58 ± 0.07 pA/lM of choline. Table 1 depicts
LOD, R2, selectivity of choline to AA (Choline : AA) and
DA (Choline : DA) in single and self-referencing modes.
These calibration parameters indicated that the microelec-
trodes were capable of detecting choline in a sensitive and
selective manner, and that the responses of the electrodes to
increasing concentrations of choline (up to 80 lM) were
highly linear (see Table 1).
Basal extracellular choline concentration in the cortex
measured in vivo
Choline-sensitive microelectrodes were employed to deter-
mine, in vivo, the concentration of extracellular choline in the
cortex (see Materials and methods for details). In intact
animals, the concentration of extracellular choline in the
frontoparietal cortex was 4.85 ± 1.12 lM (n ¼ 6). This value
is similar to basal brain extracellular choline concentration
determined by using microdialysis (Koppen et al. 1996;
Klein et al. 2002).
Clearance of exogenous and endogenous choline via
HC-3-sensitive mechanisms in the cortex in vivo
HC-3-induced decreases in the clearance of exogenous
choline
Exogenous choline (5 mM) is rapidly cleared via HC-3-
sensitive mechanisms. Figure 2(a) shows representative
traces depicting self-referenced signals in response to
pressure ejections of choline in the presence and absence
of HC-3 (see Table 2 for data). As described in Materials and
methods, the volume of pressure ejections of choline when
co-injected with HC-3, were adjusted to yield amplitudes
similar to those generated by choline alone (20–25 lM), in
order to avoid amplitude-based confounds in the calculation
Table 1 Electrode properties (calibration
data)
Analysis mode LOD (nM) R2 Choline : AA Choline : DA
Single 189.56 ± 25.1 0.991 ± 0.004 327.13 ± 60.13 0.162 ± 0.044
Self-referencing 205.09 ± 0.4 0.992 ± 0.003 266.96 ± 42.81 > 1000 ± 0.0
Data are based on 20 microelectrodes used for these experiments (mean ± SEM); LOD, limit of
detection; R2, linearity of the response of the microelectrode to increasing concentrations of
choline; AA, ascorbic acid; DA, dopamine.
Fig. 2 Representative, self-referenced traces depicting choline sig-
nals produced by pressure ejection of choline (5 mM) or KCl (70 mM),
and attenuation of clearance of exogenous as well as endogenous
choline by hemicholinium-3 (HC-3, 10 lM; see Table 2 for the effects
of both concentrations of HC-3 and for clearance data). The more
variable electrode response in (b), relative to (a), presumably reflects
the detection of choline from endogenous sources. KCl-induced cho-
line signals were previously demonstrated to be attenuated by the
co-administration of either an acetylcholinesterase inhibitor or tetro-
dotoxin, indicating that potassium-induced signals reflect choline
hydrolyzed from newly released acetylcholine (Parikh et al. 2004).
Legend for panel (a):d, choline 5 mM;s, choline 5 mm + HC-3 10 lM.
Legend for panel (b): d, KCl 5 mM; s, KCl 5 mm + HC-3 10 lM.
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of uptake rate. As a blocker of a major transporter would also
be expected to increase signal amplitude (Cass et al. 1993),
signal amplitude/ejected choline volume ratios increased
following co-pressure ejections of HC-3 (F2,21 ¼ 26.60;
p ¼ 0.001; Table 2).
HC-3 significantly reduced the uptake rate of choline
and increased the time required to clear choline; these
effects were significant with respect to both phases of
clearance (TC1, F2,21 ¼ 7.75, p ¼ 0.02; TC2, F2,21 ¼ 19.30,
p ¼ 0.002; see Table 2 for results from multiple compar-
isons). However, significant decreases in the choline
uptake rate following the smaller dose of HC-3 (1 lM)
were restricted to TC2, indicating that the blockade of
CHTs more potently affects the later phase of clearance.
Likewise, the HC-3-sensitive proportion of TC2 was 21%
(1 lM HC-3) and 41% (10 lM), compared with 11% and
30%, respectively, for TC1. Furthermore, the higher dose of
HC-3 increased the time required to clear 40–80% of the
peak choline concentration by 1858 ms, compared with
721 ms for T20)60 (see Table 2).
HC-3-induced decreases in the clearance of endogenous
choline
Previous studies demonstrated that choline signals produced
by KCl are attenuated by co-administration of either an
esterase inhibitor or tetrodotoxin, indicating that KCl-
induced choline signals reflect choline derived from hydro-
lysis of newly released ACh (Parikh et al. 2004). Figure 2(b)
illustrates a KCl-induced choline signal and the decrease in
clearance of such a signal by HC-3 (see Table 3 for a
summary of findings).
Administration of 70 mM KCl elicited choline signal
amplitudes averaging 12.65 ± 0.76 lM. Inspection of the
representative traces shown in Fig. 2(b) appears to indicate a
greater variability of the electrode response to KCl when
compared with the detection of exogenous choline, presum-
ably reflecting the two physiological processes responsible
for the depolarization-induced choline signal generation
(ACh release and hydrolysis; Parikh et al. 2004).
In contrast to experiments on the clearance of exogenous
choline (above), it was not necessary to decrease the volume
of KCl when co-injected with HC-3 in order to maintain
similar amplitudes. Thus, amplitude/ejection volume ratios
did not change following co-injection of HC-3 (F2,12 ¼ 0.81,
p ¼ 0.52, see Table 3; see Discussion for implications).
HC-3 significantly reduced the uptake of endogenously
derived choline for both the earlier and the later phase
of clearance (TC1, F2,11 ¼ 8.661, p ¼ 0.05; TC2, F2,12 ¼
18.356, p ¼ 0.021). Multiple comparisons (see Table 3)
indicated that TC1 was only affected by the higher concen-
tration of HC-3 (30% decrease). Both concentrations of HC-3
decreased the uptake rate for the later phase of clearance
(43% decrease after 10 lM HC-3).
The time required to clear 20–60% of depolarization-
generated endogenous choline was not significantly affected
by HC-3 (F2,12 ¼ 2.08, p ¼ 0.27). In contrast T40)80 was
significantly increased by HC-3 (F2,12 ¼ 12.32, p ¼ 0.036),
by 1367 ms (mean difference).
Table 2 Effect of HC-3 on the clearance of exogenous choline (5 mM)
Drugs
Signal amplitude/
ejected volume (nM/nL) T20)60 (ms) Tc1 (lM/s) T40)80 (ms) Tc2 (lM/s)
Choline (5 mM) + vehicle 94.65 ± 5.63 2117 ± 180 4.84 ± 0.50 2196 ± 170 4.39 ± 0.50
Choline (5 mM) + HC-3 (1 lM) 111.60 ± 6.41*** 2337 ± 171* 4.28 ± 0.42 3021 ± 245** 3.46 ± 0.37**
Choline (5 mM) + HC-3 (10 lM) 134.92 ± 9.78***,b 2838 ± 128**,a 3.38 ± 0.31**,a 4054 ± 419**,a 2.59 ± 0.31***,a
All data are expressed as mean ± SEM (n ¼ 8). Statistical analyses were carried out using repeated measures ANOVA followed by post-hoc
pairwise comparisons analysis using the LSD test; *p < 0.05, **p < 0.01, ***p < 0.001 vs. choline (5 mM); ap < 0.05, choline (5 mM) + HC-3 (1 lM)
vs. choline (5 mM) + HC-3 (10 lM); bp < 0.01, choline (5 mM) + HC-3 (1 lM) vs. choline (5 mM) + HC-3 (10 lM); see text for the justification of the
calculation of the ratio between signal amplitude and ejected volume.
Table 3 Effect of HC-3 on clearance of potassium-evoked choline signals
Drugs
Signal amplitude/
ejected volume (nM/nL) T20)60 (ms) Tc1 (lM/s) T40)80 (ms) Tc2 (lM/s)
KCl (70 mM) + vehicle 62.14 ± 4.61 2020 ± 95 2.63 ± 0.34 2653 ± 203 2.49 ± 0.27
KCl (70 mM) + HC-3 (1 lM) 58.32 ± 5.19 2393 ± 165 2.31 ± 0.41 3280 ± 279** 2.01 ± 0.28*
KCl (70 mM) + HC-3 (10 lM) 61.39 ± 5.16 2653 ± 395 1.84 ± 0.24* 4020 ± 498**,a 1.43 ± 0.13**,a
All data are expressed as mean ± SEM (n ¼ 5). Statistical analysis was carried out using repeated measures ANOVA followed by post-hoc pairwise
comparisons analysis using the LSD test; *p < 0.05, **p < 0.01 vs. KCl (70 mM); ap < 0.05, KCl (70 mM) + HC-3 (1 lM) vs. KCl (70 mM) + HC-3
(10 lM); see text for the justification of the calculation of the ratio between signal amplitude and ejected volume.
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Effects of cholinergic deafferentation on choline
clearance
The loss of cholinergic projections to the recording field,
produced by infusions of the immunotoxin 192-SAP into the
BF, was expected to result in a decrease in choline clearance
as a result of the loss of cholinergic terminals, and thus a
decrease in the number of CHTs available for choline uptake.
The immunotoxin has been widely demonstrated to produce
a selective loss of cholinergic neurons (e.g. Wiley et al.
1991; Holley et al. 1994; Pizzo et al. 1999); as CHTs are
selectively expressed by cholinergic neurons (e.g. Misawa
et al. 2001), the effects of the lesions on choline clearance
can be largely attributed to the decrease in CHT availability.
Histological analyses
Figure 3 illustrates the effects of lesions on CHT-positive
cells in the BF. Lesion-induced decreases in AChE-positive
fiber density and CHT-IR in the cortical recording region are
illustrated in Figs 4 and 5, respectively.
The lesion resulted in a marked loss of CHT-IR cell bodies
in the BF (Fig. 3). Semi-quantitative cell counts indicated a
significant reduction of CHT-IR cells in the nBM/SI region
[t(1,13) ¼ 17.97; p < 0.001]. In the frontoparietal recording
region, AChE-positive fiber density was markedly decreased
in lesioned animals [Fig. 4; t(1,13) ¼ 14.18; p < 0.001]. The
analyses of the effects of the lesions on choline clearance
described below were based on data from a total of seven
animals with decreases in frontoparietal AChE-positive fiber
density that were >80% when compared with the mean count
from sham-lesioned controls (n ¼ 8). Frontoparietal CHT-IR
was also decreased by the lesion [controls, 1.41 ± 0.16
(percentage immunoreactive pixels); lesioned, 0.29 ± 0.07;
t(1,13) ¼ 6.521; p < 0.001; Fig. 5].
Basal extracellular choline concentrations
Brain levels of choline are protected by potent homeostatic
mechanisms (Klein et al. 1998; Klein et al. 2002) and
thus, loss of cholinergic terminals was not expected to
affect basal extracellular concentrations (see also Zapata
et al. 2000). The results confirmed that basal extracellu-
lar choline concentrations in the frontoparietal cortex of




Fig. 3 The verification of the loss of cholinergic neurons as a result of
the infusion of 192-IgG saporin (192-SAP) at the level of the BF and as
indicated by the presence/absence of CHT-immunoreactive neurons.
(a) Low-magnification microphotograph (200 lm scalebar inserted)
showing CHT-positive neurons organized along the medial wall of the
globus pallidus (nucleus basalis of Meynert; nbM). The location of this
region is indicated on a schematic coronal section in (d). The high-
lighted region in (a) is magnified in (b) (50 lm scalebar inserted) and
exemplified the magnocellular cholinergic neurons that are charac-
teristic for the nbM and predominantly project to the cortex. Panel (c)
illustrates the almost complete absence of CHT-IR in the nbM region
following infusions of 192-SAP. (e) Estimates of CHT-positive neurons
(see Materials and methods) indicated extensive loss of these neurons
as a result of 192-SAP lesions (white bar) as compared with sham
(black bar) (***p < 0.001).
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4.85 ± 1.12 lM; lesioned, 6.83 ± 0.96 lM; t(1,10) ¼ 1.34;
p ¼ 0.21].
Cholinergic deafferentation-induced attenuation of
KCl-induced choline signals
Determination of KCl-induced choline signal amplitudes
served to verify the degree of cholinergic terminal loss in the
recording area. Figure 4(d) shows representative self-refer-
enced traces of cortical choline signals generated by pressure
ejections of 200 nL KCl (70 mM) in a sham-lesioned and a
deafferented animal. Potassium-evoked choline signals were
significantly attenuated by the loss of cholinergic projections
[t(1,13) ¼ 13.32; p < 0.001]; on average, amplitudes were
decreased by 81% relative to controls (see Fig. 4e).
Clearance of exogenous choline following loss of cholinergic
terminals
Because of the expectedly low residual amplitudes of KCl-
induced choline signals in the frontoparietal cortex of
lesioned animals (above), the effects of the lesion on choline
clearance were only assessed with respect to clearance of
exogenous choline (Fig. 5). Similarly to the experiment on
the effects of choline plus HC-3 (above), following the
lesion, choline volumes needed to be reduced in order to
produce comparable amplitudes, resulting in an increase
in the amplitude/ejected volume ratio (sham, 94.65 ±
5.63 nM/nL; lesion, 127.97 ± 5.98 nM/nL; t(1,13) ¼ 3.94;
p ¼ 0.01). Therefore, pressure ejections of choline (5 mM)
produced identical choline signal amplitudes in sham-
lesioned and deafferented rats [21.96 ± 0.52 lM and
23.07 ± 0.79 lM; t(1,13) ¼ 1.25; p ¼ 0.27; Fig. 5d].
Loss of cholinergic inputs resulted in a significant decrease
in choline clearance that manifested with respect to the later
phase of clearance [TC2, t(1,13) ¼ 11.52, p ¼ 0.009, Fig. 5e;
T40)80, t(1,13) ¼ 12.431, p < 0.001, Fig. 5f]. The effects of
the lesion on TC1 and T20)60 remained insignificant (both
p > 0.05; Figs 5e and f). Descriptively, the loss of choliner-
gic inputs reduced the choline uptake rate (TC2) by 37% and
increased the T40)80 by 1686 ms. Because the lesion
produced a marked reduction in the number of CHTs, co-
administration of HC-3 (10 lM) failed to produce additional




Fig. 4 Effects of loss of cholinergic input to the recording region on
KCl-induced choline signals. Panels (a) and (b): AChE-positive fiber
densities in the recording region from an intact (a) and a lesioned
animal (b) (50 lm scalebars are inserted). Comparison between
cholinergic fiber densities indicated a highly significant, >80% reduc-
tion in the density of cholinergic inputs to the recording region as a
result of injections of 192-IgG saporin (192-SAP, ***p < 0.001). (d)
Example of a KCl-induced signal in a sham (d) and a 192-SAP-le-
sioned (s) animal. As a result of the extensive decrease of cholinergic
terminals, KCl-induced signal amplitudes were significantly decreased
in 192-SAP lesioned (white bars) as compared with sham (black bars)
animals (e). These data confirm that the demonstration of potassium-
induced choline signals in vivo depends on the presence and integrity
of cholinergic terminals.
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p > 0.05; data not shown). The failure of HC-3 to produce
additional retardation of choline clearance in lesioned
animals further supports the selectivity of the effects of this
CHT blocker.
Correlations between histological, immunohistological
measures and choline clearance
Frontoparietal CHT-IR and TC2 choline uptake rate were
significantly correlated (Fig. 5g; sham-lesioned, r ¼ 0.81,
p ¼ 0.01; lesioned, r ¼ 0.40, p ¼ 0.03). The finding that
CHT-IR and TC2 were significantly correlated in control
animals indicates a substantial variability in the density of
frontoparietal CHTs between individual intact animals, and
that such variability is of functional significance. Further-
more, in lesioned animals, residual frontoparietal CHT-IR
and AChE-positive fiber densities were significantly corre-
lated (r ¼ 0.92, p ¼ 0.003; data not shown), substantiating
the assumption that the decrease in CHT-IR was directly
associated with the decrease in cholinergic innervation of the
recording area.
KCl-induced choline signals in the striatum of lesioned
animals
The selectivity of the lesion effects were also confirmed by
the finding that CHT-IR cell counts in the striatum did
not differ significantly between the two groups [t(1,13) ¼
0.44, p ¼ 0.66; Fig. 6]. In order to substantiate the
regional selectivity of the lesion, choline-sensitive micro-
electrodes were lowered into the striatum and choline
amplitudes were recorded following pressure ejections of
80 nL of KCl (70 mM). The amplitudes were found to be
identical in lesioned and control animals (controls,
12.06 ± 1.58 lM; lesioned, 10.58 ± 1.67 lM; t(1,4) ¼ 0.65;






Fig. 5 Effects of loss of cholinergic inputs to the recording area on
choline clearance. a, b photomicrographs of the frontoparietal
sampling region (see fig. 1d for location of the sampling area) showing
CHT-IR on a section of a sham-operated animal (a) and a 192-SAP-
lesioned animal (b; 50 lm scales are inserted). The lesion resulted in
a significant reduction of CHT-IR (see bar graph in c). (d) depicts two
representative raw (non-self-referenced) traces showing exogenous
choline clearance in the frontoparietal cortex of a sham (black circles)
and a lesioned animal (gray circles). Choline uptake rate was
decreased in lesioned (gray bars) as compared to sham (black bars)
animals; the effect reached significance in the later phase of
clearance (TC2 see e). The 192-SAP lesion (gray bars) resulted in
significant increase in the time required to clear choline for
both phases of clearance as compared to sham (black bars)
animals (**, p < 0.01; ***, p < 0.001). (g) illustrates the significant
correlations found betweem CHT-IR and TC2 in the frontoparietal
cortex of sham-operated (r ¼ 0.81) and 192-SAP lesioned animals
(r ¼ 0.40).
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Synaptosomal choline uptake under basal choline
concentrations reflecting in vivo conditions
For the in vivo experiments described above, exogenous
choline (5 mM) was pressure-ejected into the extracellular
space, which already contained 4.85 lM choline (basal
choline concentration; above). This experiment was
designed to substantiate the HC-3-sensitive component of
[3H]choline uptake in vitro by synaptosomes, under condi-
tions that approached the choline extracellular concen-
trations following choline pressure ejections in vivo.
Furthermore, the effects of local pressure-ejections are
associated with diffusion of the substrate away from the
electrode; such diffusion is inherent to the method but is of
no significance in in vitro synaptosomal assays. Thus,
evidence from this experiment assists in interpreting the
quantitative results generated by the in vivo studies des-
cribed above. A crude synaptosomal fraction was obtained
from frontoparietal cortex and pre-incubated in either the
absence or presence of 5 lM choline. [3H]Choline uptake
was determined in either the presence or absence of 10 lM
HC-3. As increases in choline concentrations results in the
dilution of the concentration of [3H]choline, saturation
kinetics for choline uptake (Km, Vmax) were not determined;
rather, choline uptake was measured at one concentration of
HC-3. In the absence of 5 lM choline in the pre-incubation
medium, HC-3 suppressed choline uptake by 74.90 ±
1.48%. Following pre-incubation of synaptosomes with
5 lM choline, HC-3-induced inhibition of choline uptake
was 43.62 ± 3.51% [without HC-3, 30.31 ± 3.97 pmol/
5min/mg protein; with HC-3, 17.08 ± 1.62 pmol/5 min/mg
protein; t(1,10) ¼ 8.02; p < 0.001]. The proportion of choline
uptake that was sensitive to HC-3, measured in the presence
of choline concentrations reflecting the concentration
observed in vivo, corresponded with the HC-3-sensitive
component of TC2 observed in vivo. Thus, this finding
substantiates the proportion of the HC-3-sensitive compo-
nent of choline clearance observed in vivo. This result also
indicates that the diffusion of the substrate away from the





Fig. 6 Striatal CHT-IR and KCl-induced choline signals were deter-
mined in order to substantiate the selectivity of the effects of infusions
of 192-SAP on the BF cholinergic projection system. Panels (a) and
(b) illustrate striatal cholinergic interneurons visualized by CHT-IR.
Estimates of the density of these neurons did not indicate a difference
between sham (black bar) and lesioned (white bar) rats (c). Likewise,
identical choline signals in response to a depolarizing stimulus (KCl)
were observed in the striatum of lesioned (s) and control (d) animals,
as exemplified in (d).
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Discussion
These experiments utilized in vivo and in vitro methods in
order to determine changes in extracellular choline concen-
tration and high-affinity CHT function in the cortex in vivo.
We report six main findings and will discuss their implica-
tions below.
(i) In vivo, cortical choline uptake via HC-3-sensitive
mechanisms represents a main mechanism for the rapid
clearance of local increases in extracellular concentrations of
choline.
(ii) CHTs contribute mostly to the clearance of choline
during the latter of the two components of the clearance
phase (TC2). The CHT-mediated clearance during this latter
component did not fundamentally depend on the source of
choline (depolarization-induced increases of endogenous
choline concentrations versus exogenous choline).
(iii) Following 192-SAP-induced cholinergic deafferenta-
tion of the recording region, depolarization-induced choline
signal amplitudes were almost completely attenuated, con-
firming that the demonstration of KCl-induced choline
signals requires acetylcholine (ACh) release and hydrolysis.
(iv) In animals with a loss of cholinergic projections to the
recording region, the decrease in clearance of exogenous
choline corresponded with the effects of HC-3 in intact
animals. Furthermore, the density of CHTs in the recording
region of lesioned animals correlated significantly with the
choline uptake rate in the later clearance phase. In intact
animals, CHT-immunoreactivty in the recording region also
was highly correlated with choline uptake rate (TC2); these
data indicate that there is considerable interindividual
variability in the density of CHTs in intact animals and that
this variability is of functional significance.
(v) Basal extracellular concentration of choline in vivo
was determined to be 4.85 lM. Loss of cortical cholinergic
inputs to the recording region did not affect basal choline
concentration.
(vi) CHT-mediated choline uptake was also determined
in vitro using a synaptosomal uptake assay and conditions
that mirror extracellular choline concentrations following
choline pressure-ejections in vivo. As diffusion of the
substrate away from the electrode surface in vivo does not
represent a variable in synaptosomal assays, collectively
these findings support the conclusion that approximately
40% of choline clearance is a result of choline uptake by
CHTs.
The attribution of the effects of HC-3 to the inhibition of
uptake via CHTs requires comment. HC-3 is a highly
selective, highly potent, competitive inhibitor of CHTs
(Ki ¼ 1–100 nM; Lockman and Allen 2002). In contrast,
the concentrations of HC-3 required to affect low-affinity
choline transport (Ki  100 lM) were not reached in the
present in vivo experiments. Based on the ratio between the
concentration of pressure-ejected choline and the concentra-
tion of choline detected by the electrode, and ignoring the
different physico-chemical properties of HC-3, we can
cautiously estimate that the highest concentration of pres-
sure-ejected HC-3 (10 lM) may have yielded <100 nM
concentrations in the recording field. A more convincing
argument in support of the selectivity of the effects of HC-3
is derived from data obtained from animals with a loss of
cholinergic projections to the recording field. Loss of
cholinergic terminals, which selectively express CHTs (e.g.
Misawa et al. 2001; Ferguson et al. 2003; Kus et al. 2003),
resulted in a decrease in choline clearance that corresponded
well with the effects of HC-3 in intact rats, indicating that the
effects of HC-3 specifically reflected the inhibition of CHTs
(see also Freeman et al. 1979; Chatterjee et al. 1987;
Saltarelli et al. 1987; Ferguson et al. 2003). Furthermore,
in lesioned animals, HC-3 was no longer able to generate
further inhibition of clearance. This finding further excludes
the possibility that the effects of HC-3 were caused by
mechanisms unrelated to the inhibition of CHTs located on
cholinergic terminals.
A second methodological issue that deserves comment
concerns the effects of either HC-3 pressure ejections or loss
of cholinergic terminals on choline signal amplitude.
Reduced clearance would be expected to be associated with
increases in signal amplitude, similar to the evidence
described in Cass et al. (1993). As described in the Materials
and methods section, volumes of pressure ejections were
adjusted to yield identical amplitudes in order to ensure that
the proportion of choline cleared by the substrate-regulated
low-affinity choline transporter remained roughly similar
across HC-3 concentrations, and to minimize amplitude-
based biases in the calculation of clearance rates. As would
be expected, the volume of pressure-ejected exogenous
choline needed to be decreased when co-injected with HC-3,
to achieve amplitudes similar to those produced by choline
alone (see the increase in amplitude/volume ratios in
Table 2).
Unexpectedly, such volume adjustment was not required
in experiments assessing the clearance of endogenous
choline following KCl pressure ejections (Table 3). As the
efficacy of HC-3 to attenuate choline clearance did not differ
between KCl-induced increases in choline concentrations
and increases caused by choline pressure ejections, the basis
for a lack of effects of HC-3 on KCl-induced signal
amplitudes remains unclear.
Diffusion of substrate away from the recording electrode
represents a variable that is difficult to control in in vivo
experiments using substrate-sensitive microelectrodes.
Although quantitative diffusion models (e.g. Nicholson
1985) assisted greatly in substantiating the conclusion that
dopamine transporters are largely responsible for dopamine
clearance (Cass et al. 1993), application of such models to
the present data is limited by the unknown proportion of
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choline clearance associated with the low-affinity choline
transporter. We are not aware of an experimental approach
available for determining the contribution of the low-affinity
transporter to choline clearance. Therefore, the results from
our in vitro synaptosomal assays are relevant to the inter-
pretation of the in vivo data. Because diffusion (of the
substrate away from the electrode) does not represent a
variable in measurements of choline uptake using synapto-
somal assays, and although the proportion of low-affinity
choline uptake transporters in a crude synaptosomal fraction
is unlikely to reflect the density of low-affinity choline
transporters in vivo, the observation that the HC-3-sensitive
component of choline uptake in vitro agrees quantitatively
with the HC-3-sensitive component of choline clearance
measured in vivo (40–43% of overall clearance) appears
informative. Moreover, this estimate appears to be in general
agreement with earlier conclusions concerning the proportion
of choline recycled for ACh synthesis (Collier and Katz
1974).
The finding that relatively high exogenous choline
concentrations were cleared as rapidly and as extensively
as KCl-induced increases in extracellular choline, via CHTs,
suggests that the capacity of CHTs does not exclusively
depend on cholinergic neuronal activity. For this discussion,
it is important to first exclude the possibility that increases in
choline concentrations depolarized cholinergic terminals.
Choline has also been suggested to act as an agonist at a7
nicotinic receptors (Alkondon et al. 1997). As nicotinic
receptor stimulation elicits choline signals (Parikh et al.
unpublished observations), choline-induced depolarization of
cholinergic neurons, either directly or involving for example
the release of excitatory amino acids (Rousseau et al. 2005),
could have contributed to the rapid CHT-mediated clearance
of exogenous choline. However, given the low micromolar
concentrations of basal extracellular choline concentrations,
and the micromolar choline signal peak amplitudes observed
following both KCl and choline pressure ejections, it seems
highly unlikely that the millimolar concentrations of choline
required to stimulate nicotinic receptors (Alkondon et al.
1997) were reached in these experiments. Indeed, as it is
difficult to envision local extracellular, endogenous choline
concentrations higher than those seen following KCl-induced
depolarization, reflecting increases in extracellular ACh by
several hundreds of percent (Herzog et al. 2003), it is not
clear whether concentrations required to stimulate nicotinic
receptors can occur in vivo (Ulus et al. 1988). This view is
also supported by the observation that choline signals evoked
by even higher concentrations of choline (20 mM) were not
affected by high concentrations of neostigmine (100 mM),
indicating that choline from endogenous sources does not
contribute to the signal recorded following such choline
pressure ejections (Parikh et al. 2004).
The present data indicate that the rate of clearance of
exogenous choline (peak amplitudes, 20–25 lM) via CHTs
does not differ fundamentally from the clearance of endog-
enous choline, generated as a result of terminal depolariza-
tion. The suggestion that a low-affinity state of the CHT
(KD ¼ 22.8 nM; Chatterjee et al. 1987) represents the func-
tionally active form of the high-affinity precursor uptake
system (Chatterjee et al. 1987) corresponds with the ability
of the CHT to clear high extracellular concentrations of
exogenous choline, specifically if it is also speculated that
increased extracellular choline concentrations trigger a
conformational change to the low-affinity state. However,
our findings on exogenous choline clearance do not suggest
that a tight coupling between high-affinity precursor uptake
and ACh synthesis (e.g. Atweh et al. 1975) represents an
exclusive mode of CHT capacity regulation. Furthermore,
our results on the effects of KCl suggest that endogenous
choline concentrations, even under conditions of extreme
activation of cholinergic neurons, may rarely exceed
10–15 lM, and thus appear to stay well within estimates of
the limits of the capacity of CHTs (Ferguson and Blakely
2004). These data also indicate that the conditions which
necessitate increased translocation of the CHT to plasma
membranes (Ferguson and Blakely 2004; Apparsundaram
et al. 2005) deserve more research.
Concerns about the degree to which high-affinity choline
uptake is coupled to ACh synthesis and release have been
raised previously (e.g. Kessler and Marchbanks 1979; Collier
and Ilson 1977). Although information about the regulation
of choline acetyltransferase (ChAT) and the vesicular trans-
porter remains incomplete, it is generally believed that these
steps do not significantly contribute to the rate-limiting
mechanisms of ACh synthesis (Yamamura and Snyder 1972).
Therefore, it may be assumed that CHT-mediated transport of
choline, including the transport of choline of exogenous
origin, serves as a precursor for ACh synthesis. Results from
prior microdialysis experiments also indicated that increased
choline concentrations, including those from dietary sources,
are taken up a HC-3-sensitive mechanisms and yield
increases in ACh release (Cohen and Wurtman 1976;
Growdon et al. 1977; Ulus et al. 1989; Koshimura et al.
1990; Marshall and Wurtman 1993; Ikarashi et al. 1997;
Koppen et al. 1997; Vinson and Justice 1997). The present
results correspond with this evidence, collectively indicating
that increases in extracellular choline from exogenous
sources, and not necessarily involving cholinergic neuronal
activity, will be cleared by CHTs.
The notion that the CHT is regulated in part by its
substrate would suggest that the functional properties of the
CHT are comparable with those of other neurotransmitter
transporters, such as the dopamine, norepinephrine or
serotonin transporters (Cass et al. 1993; Zahniser and
Doolen 2001; Zahniser and Sorkin 2004). If this assumption
is correct, it would be important to determine whether
substrate-induced trafficking, which was demonstrated for
the dopamine transporter (Chi and Reith 2003), also applies
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to the CHT. However, in contrast to evidence demonstrating
that the dopamine transporter fully accounts for dopamine
clearance (Cass et al. 1993; Giros et al. 1996; Benoit-
Marand et al. 2000), the contribution of the low-affinity
choline transporter to choline clearance in vivo remains
unsettled.
Finally, the significant correlation between CHT-IR and
choline clearance observed in intact animals suggests that the
density of CHTs in the cortex varies considerably between
animals, and that this variability is of functional significance.
In the context of previous results indicating that cognitive
performance correlated with CHT-mediated choline uptake
and the density of CHTs in plasma membrane in the cortex
(Apparsundaram et al. 2005), the present correlational results
further support the possibility that CHT-mediated choline
clearance serves as a marker predicting individual cognitive
performance.
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